• 1229 Citations
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests



Cytopathology

Certifications and Licenses

Cytopathology
Anatomic Pathology & Clinical Pathology

Training Experience

2006Residency, Allegheny General Hospital
2007Fellowship, Allegheny General Hospital

Education/Academic qualification

PhD, Beijing Medical University

… → 1991

MD, China Medical University

… → 1985

Research interests

  • Autoimmune Diseases
  • Cancer Genetics
  • Cytology
  • Pathology

Fingerprint Dive into the research topics where Xiaoqi Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Research Output

Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms

Zhu, B., Rohan, S. M. & Lin, X., 2020, (Accepted/In press) In : Cancer Cytopathology.

Research output: Contribution to journalArticle

Open Access
  • Pathologic characterization of renal epithelial neoplasms arising in nonfunctioning kidneys

    Lin, X., Goyal, R. & Yang, X. J., Mar 2020, In : Human pathology. 97, p. 1-7 7 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    A Case of Metastatic Biliary Tract Cancer Diagnosed Through Identification of an IDH1 Mutation

    Kamath, S. D., Lin, X. & Kalyan, A., Feb 2019, In : Oncologist. 24, 2, p. 151-156 6 p.

    Research output: Contribution to journalArticle

  • Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: A case report and literature review

    Chae, Y. K., Saleem, N., Roh, Y., Bilal, H., Viveiros, P., Sukhadia, B., Lin, X., Sheikh, M. M. & Park, L. C., Jul 30 2019, In : BMC cancer. 19, 1, 748.

    Research output: Contribution to journalArticle

    Open Access
  • Loss of Heterozygosity (LOH) at 17p13 and 22q13 are Shared by Breast and Thyroid Carcinomas for Metastasis

    Lin, X., Finkelstein, S. D. & Silverman, J. F., Feb 1 2019, In : Applied Immunohistochemistry and Molecular Morphology. 27, 2, p. E16-E19

    Research output: Contribution to journalArticle